This approach identified 24 mutations in 18/25 (72%) tumour samples across these regions of the APC gene, a notably higher rate than some previous studies looking at APC mutation in early-onset CRCs [20,21] that may, in part, reflect the extent of APC gene coverage by the methodology used here. This evidence concerns the gene APC and neoplasm.